Seprix-T 1.125 Injection
Marketer
Sepik Life Sciences
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Seprix-T 1.125 Injection
Seprix-T 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be under a healthcare provider's guidance. Consistent adherence to the prescribed schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation may reduce effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; consult your physician if these worsen. Seek immediate medical attention for allergic responses such as rashes, itching, swelling, or respiratory distress. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to faster recovery. Your doctor might order lab tests to monitor the medicine's impact.
Uses of Seprix-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Seprix-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Seprix-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Seprix-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Seprix-T 1.125 Injection works:
Ceftriaxone and Tazobactum, the components of Seprix-T 1.125 Injection, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Seprix-T 1.125 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seprix-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Seprix-T 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Seprix-T 1.125 Injection might cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Seprix-T 1.125 Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Seprix-T 1.125 Injection requires caution in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Seprix-T 1.125 Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Seprix-T 1.125 Injection :
Omit a Seprix-T 1.125 Injection dose? Seek medical advice immediately.
Facts to Know About Seprix-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently